These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16715091)

  • 21. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP; Kong YC
    J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
    Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
    J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
    Kohm AP; Turley DM; Miller SD
    Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation.
    Cohen JL; Salomon BL
    Cytotherapy; 2005; 7(2):166-70. PubMed ID: 16040396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of CD4+ CD25+ regulatory T cells breaks down reovirus type 2-triggered and CpG ODN-induced prolonged mild autoimmune insulitis in DBA/1 mice.
    Hayashi T; Hasegawa K; Sasaki Y; Onodera T
    Scand J Immunol; 2006 Feb; 63(2):116-24. PubMed ID: 16476010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
    Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
    J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual altered peptide ligand inhibits myasthenia gravis associated responses by inducing phosphorylated extracellular-regulated kinase 1,2 that upregulates CD4+CD25+Foxp3+ cells.
    Ben-David H; Venkata Aruna B; Sela M; Mozes E
    Scand J Immunol; 2007 Jun; 65(6):567-76. PubMed ID: 17523950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.
    Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D
    Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
    Filippi C; Bresson D; von Herrath M
    Int Rev Immunol; 2005; 24(5-6):341-60. PubMed ID: 16318986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell apoptosis and induction of Foxp3+ regulatory T cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis.
    Duarte J; Carrié N; Oliveira VG; Almeida C; Agua-Doce A; Rodrigues L; Simas JP; Mars LT; Graca L
    J Immunol; 2012 Aug; 189(4):1680-8. PubMed ID: 22802417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of CD4CD25 T cells in autoantibody production in murine lupus.
    Hsu WT; Suen JL; Chiang BL
    Clin Exp Immunol; 2006 Sep; 145(3):513-9. PubMed ID: 16907921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.